Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03691493
Title Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis (ASPIRE)
Recruitment Recruiting
Gender both
Phase Phase II
Variant Requirements No
Sponsors Emory University
Indications

Her2-receptor negative breast cancer

Therapies

Letrozole + Palbociclib

Palbociclib + Tamoxifen

Fulvestrant + Palbociclib

Anastrozole + Palbociclib

Exemestane + Palbociclib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.